The impact of adjusted work conditions and disease-modifying drugs on work ability in multiple sclerosis.

about

The impact of adjusted work conditions and disease-modifying drugs on work ability in multiple sclerosis.

Item

http://www.wikidata.org/entity/Q39272304

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

The impact of adjusted work co ...... ability in multiple sclerosis.

@en

The impact of adjusted work co ...... ability in multiple sclerosis.

@nl

type

Item

label

The impact of adjusted work co ...... ability in multiple sclerosis.

@en

The impact of adjusted work co ...... ability in multiple sclerosis.

@nl

prefLabel

The impact of adjusted work co ...... ability in multiple sclerosis.

@en

The impact of adjusted work co ...... ability in multiple sclerosis.

@nl

P1476

The impact of adjusted work co ...... ability in multiple sclerosis.

@en

P2093

Anne Wickström

http://www.w3.org/2001/XMLSchema#string

Charlotte Dahle

http://www.w3.org/2001/XMLSchema#string

Gabriel Granåsen

http://www.w3.org/2001/XMLSchema#string

Lucas Wickström

http://www.w3.org/2001/XMLSchema#string

Magnus Vrethem

http://www.w3.org/2001/XMLSchema#string

Maria Fagerström

http://www.w3.org/2001/XMLSchema#string

Peter Sundström

http://www.w3.org/2001/XMLSchema#string

P2860

Defining the clinical course of multiple sclerosis: the 2013 revisions.

Multiple sclerosis

Axonal pathology in multiple sclerosis: relationship to neurologic disability.

Improved working ability in a contemporary MS population compared with a historic non-treated MS population in the same geographic area of Sweden.

Employment among patients with multiple sclerosis-a population study.

Intense inflammation and nerve damage in early multiple sclerosis subsides at older age: a reflection by cerebrospinal fluid biomarkers.

Multivariate analyses of factors associated with unemployment in people with multiple sclerosis

Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis.

Reduced sick leave in multiple sclerosis after one year of natalizumab treatment. A prospective ad hoc analysis of the TYNERGY trial.

Improved ability to work after one year of natalizumab treatment in multiple sclerosis. Analysis of disease-specific and work-related factors that influence the effect of treatment.

P304

1137-1147

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1352458516671818

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27758955

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis